Showing results (61-70 of 240) with videos related to
Sort By:
Pageof 24
Schizophrenia Research|February 17, 2007
No association between the glutamate decarboxylase 67 gene (GAD1) and schizophrenia in the Japanese populationMasashi Ikeda, Norio Ozaki, Yoshio Yamanouchi, et al.Neuroscience Letters|May 6, 2008
A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese populationYoshihito Ito, Yukako Nakamura, Nagahide Takahashi, et al.Asian Journal of Psychiatry|March 31, 2024
Extremely Low Frequency, Extremely Low Magnetic Environment for depression: An open-label trialMasako Tachibana, Toshiya Inada, Hiroki Kimura, et al.Psychiatry Research. Neuroimaging|July 9, 2018
Aberrant functional connectivity between the thalamus and visual cortex is related to attentional impairment in schizophreniaMaeri Yamamoto, Itaru Kushima, Ryohei Suzuki, et al.Journal of Human Genetics|April 12, 2007
Gap junction coding genes and schizophrenia: a genetic association studyBranko Aleksic, Ryoko Ishihara, Nagahide Takahashi, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 11, 2008
No association between the protein tyrosine phosphatase, receptor-type, Z Polypeptide 1 (PTPRZ1) gene and schizophrenia in the Japanese populationYoshihito Ito, Shinnosuke Yamada, Nagahide Takahashi, et al.Neuroscience Letters|September 6, 2005
No association between monoamine oxidase A promoter polymorphism and personality traits in Japanese femalesYuko Hakamata, Nagahide Takahashi, Ryoko Ishihara, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 2, 2008
Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in JapanHiroyuki Uchida, Takefumi Suzuki, David C Mamo, et al.PCN Reports : Psychiatry and Clinical Neurosciences|July 13, 2026
An open-label, long-term extension, multicenter study to evaluate the safety and efficacy of venlafaxine extended release in Japanese outpatients with generalized anxiety disorderTempei Otsubo, Koichiro Watanabe, Takeshi Inoue, et al.Psychiatry and Clinical Neurosciences|October 22, 2025
A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release in Japanese patients with generalized anxiety disorderTempei Otsubo, Koichiro Watanabe, Takeshi Inoue, et al.Pageof 24